Patents by Inventor Ümit Cifter

Ümit Cifter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations comprising plant extracts
    Patent number: 10111925
    Abstract: The present invention is related to a formulation comprising Hedera helix, Pelargonium sidoides, and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: October 30, 2018
    Assignee: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • Inhalation compositions comprising glucose anhydrous
    Patent number: 10111957
    Abstract: The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: October 30, 2018
    Assignee: Arven Ilac Snayi ve Ticaret A.S.
    Inventors: Ümit Cifter, Ali Turkyilmaz, Onur Mutlu
  • Herbal formulations
    Patent number: 10111912
    Abstract: The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: October 30, 2018
    Assignee: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • Inhalation compositions comprising muscarinic receptor antagonist
    Patent number: 10105316
    Abstract: The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: October 23, 2018
    Assignee: Arven llac Sanayi ve Ticaret A.S.
    Inventors: Ümit Cifter, Ali Turkyilmaz, Onur Mutlu
  • Formulations comprising herbal extracts
    Patent number: 9913869
    Abstract: The present invention relates to a formulation comprising extracts of Hedera helix, Pelargonium sidoides and Echinacea purpurea for use in the treatment, prevention of, or the alleviation and/or elimination of the symptoms of various respiratory tract diseases, as well as to a method for preparing this formulation.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: March 13, 2018
    Assignee: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • Stable formulations
    Patent number: 9907824
    Abstract: The present invention relates to a formulation comprising extracts of Hedera helix and Pelargonium sidoides for use in the treatment, prevention of, or the alleviation and/or elimination of the symptoms of various respiratory tract diseases, as well as a method for preparing this formulation.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: March 6, 2018
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • ZALTOPROFEN AND MUSCLE RELAXANT COMBINATIONS
    Publication number: 20170189374
    Abstract: The present invention relates to a novel pharmaceutical composition comprising zaltoprofen or a pharmaceutically acceptable salt thereof in combination with muscle relaxants with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: July 20, 2015
    Publication date: July 6, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, AYSE ILDES ERDEM, EDIZ YILDIRIM, TUTKU CEREN KARABULUT
  • LOXOPROFEN AND GAMMA-AMINOBUTIRIC ACID RECEPTOR AGONIST COMBINATIONS
    Publication number: 20170151177
    Abstract: This invention is a novel pharmaceutical composition comprising loxoprofen or a pharmaceutically acceptable salt thereof in combination with gamma-aminobutiric acid receptor agonist or a pharmaceutically acceptable salt thereof with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: June 29, 2015
    Publication date: June 1, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, SEVAL ATAMAN, AYSE ILDES ERDEM, GAYE RAMAZANOGLU
  • A NOVEL PHARMACEUTICAL COMPOSITION OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170151272
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin as active agents with at least one pharmaceutically acceptable excipient, wherein at least one of the active agents is in the form of controlled release, for use in the treatment of hepatitis C virus infections, chronic hepatitis C, hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: June 1, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170128482
    Abstract: This invention is a novel modified release pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 11, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170112867
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: April 27, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • HERBAL FORMULATIONS
    Publication number: 20150290253
    Abstract: The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
    Type: Application
    Filed: October 17, 2013
    Publication date: October 15, 2015
    Applicant: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit CIFTER, Nazife ARABACIOGLU, Özlem TOKER
  • FORMULATIONS COMPRISING HERBAL EXTRACTS
    Publication number: 20150290268
    Abstract: The present invention relates to a formulation comprising extracts of Hedera helix, Pelargonium sidoides and Echinacea purpurea for use in the treatment, prevention of or the alleviation and/or elimination of the symptoms of various respiratory tract diseases, as well as to a method for preparing this formulation.
    Type: Application
    Filed: October 17, 2013
    Publication date: October 15, 2015
    Inventors: Ümit CIFTER, Nazife ARABACIOGLU, Özlem TOKER
  • NEW FORMULATIONS COMPRISING PLANT EXTRACTS
    Publication number: 20150273009
    Abstract: The present invention is related to a formulation comprising Hedera helix, Pelargonium sidoides, and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
    Type: Application
    Filed: October 17, 2013
    Publication date: October 1, 2015
    Applicant: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • STABLE FORMULATIONS
    Publication number: 20150273003
    Abstract: The present invention relates to a formulation comprising extracts of Hedera helix and Pelargonium sidoides for use in the treatment, prevention of, or the alleviation and/or elimination of the symptoms of various respiratory tract diseases, as well as a method for preparing this formulation.
    Type: Application
    Filed: October 17, 2013
    Publication date: October 1, 2015
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker